Page 7 - Best Brain MRI doctors: TOP 219 doctors

SPECIAL PROCEDURES:

• Introduction of laser spine surgery
• Minimally invasive microscopic spine surgery as part of one-day care

PUBLICATIONS:

• Video clinic

Memberships

Hungarian Society of Neurosurgery

Awards, recognitions

In 1981, he was awarded an honorary professorship in Japan, an Outstanding Doctor award, and was featured in the Video Portrait Hall of Outstanding Persons.

International experience

Study trips to many European countries and Japan, giving more than 100 lectures at national and international congresses

Dr. Mehmet Tonge is a neurosurgeon with expertise in Stereotactic and Functional Neurosurgery. He specializes in MR Guided Focused Ultrasound, deep brain stimulation, Gamma Knife Radiosurgery, and surgery for movement disorders, pain, and spasticity.

Dr. Tonge has published 32 articles in international and national journals and written 12 book chapters. He has presented 92 oral and poster presentations and delivered 41 invited lectures. He completed a Deep Brain Stimulation Fellowship at Maastricht University and finished the 4-year EANS training cycle. Dr. Tonge is known for his research and clinical work in functional neurosurgery.

Dr Romero Imbroda is an academic of the Royal Academy of Medicine of Eastern Andalusia and a Fellow of the European Board of Neurology, as well as a Member of the Board of Directors of the

Andalusian Society of Neurology. He combines his medical practice with his teaching role at the University of Granada, where he is a Lecturer and has been a Member of the Internal Residential Doctor Assessment Committee in Melilla until 2017.

He is the author of several national and international scientific publications. He has also participated in research projects associated with treatments for multiple sclerosis.

Professional Experience:

• 2020: President of the Andalusian Society of Neurology

• 2019: Head of the Units at the Quirónsalud Malaga and Marbella Hospitals

• 2017-2021: Neurologist at the Regional Malaga University Hospital.

• 2016-2017: Lecturer at the University of Granada.

• 2009-2017: Neurologist at the Imbrain Neuroscience Clinic. Melilla.

• 2009-2017: Neurologist at the Melilla Hospital.

• 2008-2009: Neurologist at the Virgen de las Nieves Hospital. Granada.

• 2004-2008: Neurologist at the Carlos Haya Hospital. Malaga.

Academic Training:

• 2017: Innovation and Leadership in Neurology. Business Institute. Madrid.

• 2014: Educational Commission for Foreign Medical Graduates. United States.

• 2011-2012: Management of Integrated Health Services. ESADE. Madrid.

• 2010: Neurologists for the Future. Spanish Neurology Society.

• 2010: Master in Tissue Engineering. University of Granada.

• 2010: Doctorate at the University of Granada. Summa Cum Laude. 2010.

• 2004-2008: Neurology specialist at the Carlos Haya Hospital. Malaga.

• 1997-2003: University Graduate in Medicine at the University of Granada.

The Neurology Unit of the Quirónsalud Marbella Hospital specialises in the study and treatment of conditions associated to the nervous system, the brain, the spinal cord, the peripheral nerves and the muscles. We have the most advanced technology that enables us to make accurate and personalised diagnoses and treatments in the study of patients with complex diagnoses and treatments (MRI, CT scan,electroencephalogram, transacranial doppler ultrasound, cerebral arteriogramand neuropschycological testing).

We offer our patients highly-specialised treatments for cerebrovascular and neuromuscular diseases, Parkinson's Disease, headaches and migraine, epilepsy, multiple sclerosis, peripheral neuropathies, infections of the nervous system, movement disorders, dementia and other cognitive conditions, paediatric neurology, sleep disorders, tumours and complications deriving from injuries to the spine and the head.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professional experience

Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.

Membership in scientific societies

National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)

President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).

Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).

Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).

Research and Teaching

Principal investigator of 100 national and international clinical trials.

7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).

10 projects from private foundations, received on a competitive basis (7 as principal investigator).

He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).

His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.

Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.

Education :

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Experience

2019 – 2019

• University of Insubria, Varese, Italy, 

Insubria University Faculty of Medicine

2015

• MERSİN UNIVERSITY/FACULTY OF MEDICINE, DOCTOR, LECTURER

2013 – 2015

• ANKARA PRIVATE ACIBADEM HOSPITAL

2010 – 2012

• DIYARBAKIR TRAINING AND RESEARCH HOSPITAL,

2002 – 2003

• AYDIN 1ST PRIVATE TRAINING BATTALION
•  

Education

2010

• ANKARA UNIVERSITY FACULTY OF MEDICINE, BRAIN AND SURGERY SPECIALIST

1992

• GAZI UNIVERSITY, FACULTY OF MEDICINE

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education

2005 – 2011 | Kocaeli University, Faculty of Medicine, Kocaeli, Turkey
M.D. Degree

2013 – 2019 | Erenköy Mental Health and Neurology Training and Research Hospital, Istanbul, Turkey
Neurology Residency Program

Languages

English – Very Advanced

Professional Experience

Artvin Borçka State Hospital, Artvin, Turkey
General Practitioner (Compulsory Service)
2011 – 2012

Erenköy Mental Health and Neurology Training and Research Hospital, Neurology Department, Istanbul, Turkey
Resident Physician
2013 – 2019

Siirt State Hospital, Siirt, Turkey
Neurology Specialist (Compulsory Service)
2019 – March 2021

Private Pendik Medical Park Hospital, Istanbul, Turkey
Neurology Specialist
April 3, 2021 – April 10, 2024

Bahçeşehir University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Assistant Professor
April 19, 2021 – June 1, 2024

Medipol Acıbadem Regional Hospital, Istanbul, Turkey
Associate Professor of Neurology
April 22, 2024 – Present

Istanbul Medipol University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Associate Professor of Neurology
November 11, 2024 – Present

Memberships

Turkish Neurology Society

Turkish Medical Association

International Parkinson and Movement Disorder Society

Turkish Neurology Society Neurorehabilitation Working Group

Global Migraine and Pain Society

International Headache Society

Turkish Parkinson’s Disease Society

Turkish Alzheimer Association, Kadıköy Branch

Areas of Interest

Parkinson’s disease and other movement disorders

Migraine and other headache disorders

Sleep disorders

Dementia and Alzheimer’s disease

EEG, Polysomnography (PSG), Multiple Sleep Latency Test (MSLT)

Botulinum toxin injections for movement disorders

Nerve blocks and botulinum toxin for headache management

Epilepsy

Education and Expertise

1988: Istanbul University Cerrahpaşa Faculty of Medicine, Medical Education, Istanbul

1996: Haydarpaşa Numune Training and Research Hospital, Brain and Neurosurgery Clinic, Neurosurgery Specialist Training, Istanbul

Experience

1989 to 1996: Haydarpaşa Numune Training and Research Hospital, Brain and Neurosurgery Clinic, Assistant Doctor, Istanbul

1996 to 1999: Private Respect Hospital, Specialist Doctor and Chief Physician, Istanbul

2000 to 2002: Bakırköy Mental and Neurological Diseases Training and Research Hospital, 1st Neurosurgery Clinic, Specialist Doctor, Istanbul

2002 to 2010: Ministry of Health Pendik State Hospital, Specialist Doctor, Istanbul

2008 to 2009: Participation in "Spinal Surgery Program" at Istanbul American Hospital Neurosurgery Clinic. Fellowship Days: 01.05.2008 - 31.12.2009

2010 to 2011: University of California Los Angeles (UCLA), Santa Monica Hospital Center for Spinal Surgery (Comprehensive Spine Center), Researcher (Fellow), California, USA

2011: Associate Professor

2014: Virginia University Faculty of Medicine, Department of Brain and Neurosurgery, Visiting Faculty Member, Charlottesville, Virginia, USA

2012 to 2016: Istanbul Medeniyet University Faculty of Medicine, Department of Brain and Neurosurgery, Istanbul

2016 to 2018: Vital Fulya Plaza, Fulya/Beşiktaş/Istanbul

Professional Memberships

-Turkish Neurosurgery Association
-Turkish Neurosurgery Association, Spinal and Peripheral Nerve Surgery Teaching and Training Group
-Turkish Spine Association
-AO Spine International
-Society for Minimal Intervention in Spinal Surgery
-Turkish Neurosurgery Association, Surgical Neurosurgery Group
-Scoliosis Research Society (SRS)

 

Education & Academic Background

GATA School of Military Medicine – Medical Degree

GATA Haydarpaşa Training Hospital, Neurosurgery Clinic – Specialization in Neurosurgery

Beykent University – Master’s Degree in Hospital and Health Institutions Management

Professional Experience

GATA Military Medical Faculty – Internship in General Medicine 

Samsun Field (Sahra) Medical School Command – Physician 

Naval Command, Combat Fleet, TCG Effort – Medical Officer 

Submarine Battery Factory Infirmary, Turkish Naval Forces – Physician

Shipyard Command Infirmary, Turkish Naval Forces – Physician 

GATA Haydarpaşa Training Hospital – Chief Assistant, Neurosurgery Department 

Kasımpaşa Marine Hospital – Chief of Neurosurgery Clinic 

Bahçelievler Medical Park Hospital – Neurosurgery Specialist

Altınbaş University Faculty of Medicine – Neurosurgery Lecturer

Altınbaş University Faculty of Medicine, Department of Neurosurgery – Faculty Member 

Certifications & Courses

-Basic and Advanced Cardiac Life Support (BLS & ACLS) Courses

-GATA Military Medicine Faculty – Microsurgery Training Course

-Istanbul Vatan Hospital – Hand Surgery & Microsurgery Course

-Neuroanatomy Course

-Spine Surgery Course

Professional Memberships 

-Turkish Neurosurgery Association 
-Spine Society of Europa
-Turkish Spinal and Peripheral Nerve Surgery Group

Research & Publications

Transpedicular fixation application in thoracic and lumbar stabilization, results and complications.
Yayla O, Demircan MN, Kutlay M, Çolak A, Seçer HI, Kıbıcı K, Tosyalı L, Akın ON, Alkan K. GATA Bulletin.

Effects of hyperbaric oxygen therapy on histopathological changes in acute period after crush trauma in rabbit sciatic nerve.
Akın ON, Kutlay M, Demirel D, Kıbıcı K, Elbüken E. J Atatürk Univ Med Fac.

Early diagnosis, follow-up and treatment of delayed traumatic intracerebral hematomas.
Kutlay M, Kıbıcı K, Demircan MN. Natl J Trauma.

Traumatic delayed epidural hematomas: Retrospective analysis of 7 new cases and 48 from literature.
Kutlay M, Çolak A, Kıbıcı K, Demircan MN, Akın ON. Natl J Trauma 1998.

Single vertebral body screw-rod or plate fixation for ventral thoracic spine lesions.
Kutlay M, Çolak A, Demircan MN, Akın ON, Kıbıcı K, Seçer HI, Tosyalı L. Turk Neurosurg 1999.

Peripheral nerve schwannomas.
Kutlay M, Çolak A, Akın ON, Demircan MN, Kıbıcı K, Topuz K, Başekim Ç, Demirel D. Turk J Neurosurg  1999.

Epidemiological study of traumatic spinal cord injuries.
Kutlay A, Kıbıcı K, Demircan MN. GATA Bulletin  1999.

Hyperbaric oxygen treatment on fetal spinal cord grafts: Preliminary study.
Kutlay M, Çolak A, Demircan MN, Akın ON, Kıbıcı K, Dündar K, Yıldırım Ş. Turk Neurosurg, 1999.

Corpus callosum lipomas with frontal subcutaneous lipomas.
Çolak A, Kutlay M, Başekim Ç, Kıbıcı K, Demircan MN. Gülhane Med J,  2000.

Morphometric study with image analysis system in meningiomas.
Kıbıcı K, Kutlay M, Çolak A, Demircan MN, Akın ON, Baloğlu H. Turk J Neurosurg, 2003.

Morton Neuroma with Tarsal Tunnel Syndrome: Case report.
Kıbıcı K, Demircan MN, Kıral A, Çolak A, Kutlay M, Akın ON. Turk J Neurosurg, 2006.

Carpal tunnel surgery with mini open technique: Functional results.
Kıbıcı K. Turk J Neurosurg, 2010.

Surgical treatment of common peroneal nerve entrapment: Clinical study.
Kıbıcı K. Turk J Neurosurg,  2010.

Cauda equina syndrome after sacrum transverse fracture: Case report.
Köksal V, Kıbıcı K. Turk J Neurosurg,  2010.

Schwannoma from sensory sural nerve: Case report.
Köksal V, Kıbıcı K. Erciyes Med J,  2013.

Clinical analysis of wrist drop due to radial tunnel syndrome.
Köksal V, Kıbıcı K, Kırbaş S. Indian J Med Res Pharm Sci,  2016.

Spinal subdural hematoma after minimally invasive lumbar discectomy.
Kıbıcı K, Atca AÖ, Erok B, Gültekin MZ. J Clin Rev Case Rep,  2019.

Rare variant of vertebral artery originating from external carotid artery.
Kıbıcı K, Atca AÖ, Erok B. J Clin Rev Case Rep,  2019.

Minimally invasive surgical treatment of piriformis syndrome.
Kıbıcı K, Atca AÖ, Erok B. J Clin Rev Case Rep,  2019.

Large suprasellar psammomatous meningioma: A rare variant.
Erok B, Kıbıcı K, Kaya RA. Pak J Radiol,  2020.

Large pericallosal lipoma after traumatic head injury: Case report.
Erok B, Kıbıcı K, Atca AÖ. Pak J Radiol,  2020.

Fungating orbital mass as presentation of retinoblastoma.
Kıbıcı K, Erok B, Akın O. J Acad Res Med, 2020.

Ligamentum flavum hematoma with L5-S1 pars defect: Case report.
Kıbıcı K, Erok B, Akın O. Indian J Neurosurg,  2020.

Radiation-induced brachial plexopathy in breast cancer: Surgical role.
Kıbıcı K, Erok B, Atca AÖ. Indian J Neurosurg, , 2020.

Drop foot due to peroneal intraneural ganglion: Case report.
Kıbıcı K, Erok B, Akın O. Indian J Neurosurg,  2020.

Surgical decompression of lateral femoral cutaneous nerve in meralgia paresthetica.
Kıbıcı K, Erok B, Atca AÖ. Indian J Neurosurg,  2020.

Pulmonary cavitation in COVID-19: Primary or secondary?
Erok B, Kıbıcı K, Atca AÖ. Afr J Respir Med,  2020.

Posterior dynamic stabilization for bilateral L5 pars defect.
Kıbıcı K, Erok B. Turk Neurosurg, , 2020.

Incidental MRI appearance of COVID-19 pneumonia.
Atca AÖ, Erok B, Kıbıcı K. Afr J Respir Med,  2020.

Orbital rhabdomyosarcoma in Li-Fraumeni syndrome.
Erok B, Kıbıcı K. Eur J Clin Exp Med,  2021.

Chest CT features of progressive COVID-19 pneumonia.
Erok B, Atca AÖ, Kıbıcı K. Acta Med Mediterr, 2021.

Academic Details

Faculty / University
19 Mayis University, Faculty of Medicine, Samsun – Turkey

Date of Graduation
1992

Postgraduate Training
Institution: Department of Radiology, Faculty of Medicine, Erciyes University, Kayseri – Turkey
Supervisor in Charge of Training: Mustafa Ozturk
Training Period: From 1993 to 1998
Title of Thesis: Evaluation of Lower Extremity Artery-Occlusive Disease by MR Angiography

Accreditation

Radiology Specialist: 1998, The Ministry of Health of Turkey

Associate Professor: 2003, Interuniversity Committee

Academic Experience

Residency: Department of Radiology, Erciyes University, Kayseri – Turkey (1993 to 1998)

Private Practice: Maternal and Children Hospital, Sivas – Turkey (1998–2000)

Academic Positions:

2000 to 2003: Assistant Professor of Radiology, Firat University, Elazig – Turkey

2003 to 2009: Associate Professor of Radiology, Firat University, Elazig – Turkey

2009 to 2010: Professor of Radiology, Firat University, Elazig – Turkey

2010 to 2015: Professor of Radiology, Chairman, Bezmialem Vakif University, Istanbul – Turkey

2015 to 2016: Professor of Radiology, Chairman, Yeditepe University, Istanbul – Turkey

2017 to Present: Professor of Radiology, Interventional Radiology Unit, Bahçelievler Medical Park Hospital, Altınbaş University, Istanbul – Turkey

Fellowship

Institution: Department of Radiology, University Hospital of Cleveland, Case Western Reserve University, Cleveland, Ohio, USA

Duration:  2004 to 2005

Position: Research Fellow – Ultrasound & CT (Body)

Professional Memberships

-Turkish Society of Radiology

-Medical Ultrasound Society of Turkey

-Turkish Society of Radiology, Abdominal Radiology Study Group

-ESGAR – European Society of Gastrointestinal and Abdominal Radiology (Fellow)

-ESUR – European Society of Urogenital Radiology (Fellow)

-ESR – European Society of Radiology

-Turkish Society of Magnetic Resonance

-Turkish Society of Radiology, Urogenital Radiology Study Group

-Turkish Society of Interventional Radiology

-Korean Society of Radiology (International Member)

-Radiological Society of North America (RSNA) – Corresponding Member

Prizes and Awards

European Congress of Radiology (ECR) 2002, Vienna – Image Interpretation, 3rd Prize

Interpretation Corner of European Radiology 2003 – 2nd Prize

Cases of the Day – ESGAR 2007, Lisbon, Portugal – 2nd Prize

Cases of the Day – ESGAR 2009, Valencia, Spain – 1st Prize

Dr. Evren Sandal is a specialist in Brain and Neurosurgery. He completed his medical degree at Ege University Faculty of Medicine. He finished his neurosurgery training in 2015. Dr. Sandal focuses on skull base, craniocervical junction, and neurovascular surgery. He has extensive experience in these fields.

Dr. Sandal has worked at the Health Sciences University Tepecik Training and Research Hospital. He also contributed to laboratory and clinical studies in skull base and cerebral bypass surgery at the University of Wisconsin, USA. He has collaborated with experts such as Prof. Dr. M. Sedat Çağlı and Prof. Başkaya. These experiences have strengthened his skills in complex neurosurgical procedures.

Neurologist

Dr. Ulvi Samadzade is a neurologist with training from Azerbaijan State Medical University, Gazi University, and Dokuz Eylul University Hospital. He diagnoses and treats neurological disorders such as Alzheimer’s disease, epilepsy, movement disorders, stroke, migraine, and multiple sclerosis.

Dr. Samadzade uses advanced treatments, including botulinum toxin injections, intravenous immunoglobulin (IVIG) therapy, migraine vaccines, and plasmapheresis. He practices at İzmir University of Economics Medical Point Hospital.

He is a member of several professional organizations. These include the Multiple Sclerosis Research Association, Turkish Neurological Society, European Academy of Neurology, and the International Parkinson and Movement Disorder Society (MDS).

Somjet Tosamran, MD, is a neurologist. Dr. Tosamran is a fellow in epilepsy at the Neurology Division, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand (2024–present). Dr. Tosamran completed a neurology residency at the same hospital (2021–2024). Earlier training includes internships at Charoenkrung Pracharak Hospital and Sakaeo Crown Prince Hospital.

Accreditations and education: Neurologist certification, King Chulalongkorn Memorial Hospital (2024). Master of Science in Internal Medicine, Faculty of Medicine, Chulalongkorn University (2024). Doctor of Medicine, First Class Honors, Faculty of Medicine, Chulalongkorn University (2018).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.